Maine’s joint rule took effect in July 2026, addressing patient evaluations, prescribing, delegation, and medication compounding while clarifying that the same professional standards apply as in other health care settings.
Maine Licensing Boards Implement Joint Rule for Medical Aesthetic and IV Services
On July 14, 2026, Maine’s Chapter 15 joint rule governing health care services and procedures in Med Spas, IV therapy businesses, and medical aesthetic businesses took effect. The Board of Licensure in Medicine, State Board of Nursing, and Board of Osteopathic Licensure jointly adopted the rule. For Med Spa, medical aesthetic, and IV therapy operators, Chapter 15 clarifies clinical responsibilities and standards of practice without expanding licensees’ existing scope of practice.
Requirements Outlined In Maine’s Joint Med Spa and IV Therapy Rule
Previously under review as a proposed joint rule for IV therapy and Med Spa services, Maine’s Chapter 15 now establishes requirements for patient evaluations, treatment authorization, and medication preparation.
Scope of Practice and Practice Standards
Section 2 defines key terms, including authorized licensee, health care services, and compounding.
Section 3’s key requirements include:
- IV administration: Parenteral and IV preparations require prior appropriate examination and diagnosis by a physician, physician associate, or APRN within a valid licensee-patient relationship [3(2)(A)].
- Professional standards: Existing scope limits, standards of care, and professional ethics continue to apply [3(3)–(4)].
- Clinical assessments: Physicians, physician associates, and APRNs generally must conduct an in-person clinical interview and physical examination, while RNs generally must conduct an in-person clinical interview and pertinent nursing assessment. Telehealth may be used when the technology supports an informed diagnosis or nursing assessment equivalent to an in-person encounter. A static questionnaire does not satisfy either standard [3(6)–(7)].
- Standing orders: Their use for individualized assessment, diagnosis, and treatment constitutes unprofessional conduct [3(11)].
Sections 3(9)–(10) also require documented informed consent and complete, accurate, timely patient records.
Compounding Medications and Drug Shortage Practice Standards
Section 4(6) requires IV administration under valid prescriber orders rather than patient-driven menu selection.
Additional requirements include:
- IV preparation: Mixing saline with additives must comply with state and federal compounding requirements. Clinic or office compounding where solutions are administered requires a licensed physician and legally recognized reasons [4(2), 4(7)].
- Immediate use: Section 4(10) excludes walk-in, mobile, and concierge IV services from the USP <797> immediate-use exception.
- Drug shortages: Section 5(1) requires prescribers to document support for elective or nonmedical use of drugs listed in FDA’s shortage database when prescribed.
These requirements reflect the purpose outlined in Section 1(3), which distinguishes traditional aesthetic services from medical services requiring licensed professionals. Section 6 (1) classifies violations of the rule as unprofessional conduct.
Source Attribution
According to a July 29, 2026, newsletter from the Maine Board of Licensure in Medicine, Chapter 15 became effective July 14, 2026. The full rule is publicly available through the Maine Department of the Secretary of State.
Compliance Considerations for Maine Med Spas and IV Therapy Businesses
Chapter 15 addresses potential confusion about which services require licensed professionals and whether IV hydration constitutes medical care, as outlined in Sections 1(3)–(4).
Section 2 identifies the business settings covered by the rule:
- Medical aesthetic business: Provides services such as neurotoxin treatment, dermal fillers, laser treatments, and medical weight loss treatment [2(10)].
- Med Spa: Offers appearance-focused aesthetic procedures that require no sedation and do not meaningfully support bodily function or prevent or treat illness or disease [2(11)].
- IV therapy business: Provides IV fluids through a walk-in or mobile business, with or without additives such as prescription drugs, vitamins, minerals, nutrients, or amino acids [2(8)].
For menu-based IV services, Sections 1(4)–(7) explain that patient-selected treatments may overlook conditions precluding an infusion. Individualized clinical evaluation and prescribing remain necessary.
Staffing and business arrangements also carry specific limits. Training certificates do not constitute licensure, and ownership or medical-director designation alone does not establish the required patient relationship [1(8)–(9)]. Medical evaluation, diagnosis, and prescribing cannot be delegated to individuals without prescriptive authority, including RNs. Section 3(8)(B) also prohibits delegating medication administration to unlicensed personnel.
IV preparation carries additional requirements beyond treatment authorization. Section 4(7) requires a licensed physician to compound solutions in clinics or offices where they are administered, for legally recognized reasons rather than patient menu selection.
Related considerations about clinical participation and staff roles appear in the Oregon nursing board’s IV hydration and aesthetic guidance and the Georgia medical board’s IV therapy statement, each operating within its own state’s requirements.
Chapter 15 reinforces standards of care without expanding licensees’ scope of practice in Med Spas, medical aesthetic businesses, and IV therapy businesses.
Practical Implications for Maine Med Spas, Medical Aesthetics, and IV Therapy Businesses
- Confirm that a physician, physician associate, or APRN evaluates the patient before IV therapy.
- Distinguish traditional aesthetic services from medical services, including IV therapy, when applying clinical requirements.
- Obtain an individualized order for each IV preparation and treatment.
- Verify that a licensed physician performs any compounding in a clinic or office where the IV solutions are administered.
- Document patient evaluations, informed consent, IV products, treatment, and follow-up in the medical record.
What to Watch Next
Chapter 15 took effect July 14, 2026, and does not expand licensees’ scope of practice. The Maine Board of Licensure in Medicine lists September 8, 2026, as its next scheduled meeting. Further updates or statements from the participating boards may provide additional information for Med Spas, medical aesthetic businesses, and IV therapy businesses.
About Spakinect
Spakinect provides compliance infrastructure and telehealth-supported supervision solutions for medical aesthetic practices. For additional information, see our website.
Image Attribution: “Maine State House, State Street and Capitol Street, Augusta, ME” by w_lemay, via Wikimedia Commons, licensed under CC BY-SA 4.0.
